Jean Jacques Mambo Bell✍🏽
About Jean Jacques Mambo Bell✍🏽
Jean Jacques Mambo Bell serves as EMEA Sales at ArisGlobal in Edinburgh, Scotland, where he focuses on transforming drug development processes for life sciences companies across Europe, the Middle East, and Africa.
Work at ArisGlobal
Jean Jacques Mambo Bell has been working at ArisGlobal as EMEA Sales since 2023. Based in Edinburgh, Scotland, he focuses on collaborating with life sciences companies across Europe, the Middle East, and Africa. His role involves transforming drug development processes through ArisGlobal's software solutions. He actively contributes to the company's growth by generating leads, closing deals, and fostering long-term client relationships. Additionally, he partners with key decision-makers to understand their needs and demonstrate the value of ArisGlobal's offerings.
Education and Expertise
Jean Jacques Mambo Bell studied at Abertay University, where he pursued a Bachelor's degree in Business, Management, Marketing, and Related Support Services from 2006 to 2012. His educational background provides a solid foundation for his career in sales and business development. He has developed expertise in the fintech and collaboration software sectors, which he has applied in his roles at various companies.
Background
Before joining ArisGlobal, Jean Jacques Mambo Bell held several positions in sales and account management. He worked at Mattermost as a Sales Development Representative from 2021 to 2022 and served as an Account Executive for EMEA at Revolut from 2022 to 2023. His earlier experience includes a role as National Account Manager at Chetu, Inc. from 2019 to 2020. This diverse background has equipped him with valuable insights into client needs and market dynamics.
Professional Experience
Jean Jacques Mambo Bell has accumulated significant experience in sales and account management across various industries. His tenure at Mattermost and Revolut allowed him to develop skills in sales strategy and client engagement. At ArisGlobal, he leverages this experience to enhance drug development processes for life sciences companies, ensuring compliance and efficiency in their operations.